StockWatch
·
Pharmaceuticals
Shareholding17 Nov 2026, 04:41 pm

Mukund Kakani Converts Warrants to 1.56L Shares in Godavari Drugs

AI Summary

Mukund Kakani, Managing Director of Godavari Drugs Limited, has converted 1,56,334 convertible warrants into an equal number of equity shares. This transaction, effective November 17, 2026, resulted in a change in his shareholding. Before the conversion, Kakani held 8,19,000 warrants, representing 7.50% of the total capital and 4.64% on a diluted basis. After the conversion, he holds 8,19,000 equity shares, representing 5.66% of the total capital and 6.56% on a diluted basis. The total equity share capital of the company increased from ₹10,91,41,250 to ₹11,70,08,150, with the total diluted share capital rising to ₹12,48,75,000.

Key Highlights

  • Mukund Kakani converted 1,56,334 warrants into equity shares.
  • His post-conversion holding is 8,19,000 shares (5.66% of total capital).
  • The conversion impacts diluted shareholding to 6.56%.
  • This is a conversion of convertible securities into shares.
  • The transaction is classified as a shareholding change.